Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Am J Transplant. 2017 Aug 14;17(11):2945–2954. doi: 10.1111/ajt.14415

Figure 2. Treg manufacturing.

Figure 2

Parameters of Treg manufacturing for the three kidney transplant patients in this study - TASKp (pilot Treg adoptive therapy for subclinical kidney transplant inflammation, n=3) (solid symbols) are compared with those obtained from type 1 diabetes patients (T1D) enrolled in a separate trial (n=14) (12)(open symbols). Identical standard operating procedures were followed in the two trials. Mann Whitney test was used to calculate p values and determine the statistical significance between the two groups.